Medical/Pharmaceuticals News & Press Release Distribution

Medical/Pharmaceuticals

APAC
Global

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

SONGDO, South Korea, July 15, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics held a signing ceremony today for a contract to develop and manufacture five candidate molecules, expanding upon the two companies' existing CDO partnership first established in 2018. ...

2020-07-15 13:46 1832

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Bridge Biotherapeutics becomes BaseLaunch's first Asia Pacific partner

SEONGNAM, South Korea and BASEL, Switzerland, July 14, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc.(KOSDAQ: 288330), a clinical stage biotech company headquartered in Seongnam, Republic of Korea and BaseLaunch, theBasel Area -based biotech venture accelerator and incubator, today announces tha...

2020-07-15 07:00 14432

Mexico Telecommunication Giant, Alestra, Deploys Bright Pattern Contact Center Software for CENACED's Telehealth Services During COVID-19

Alestra, deploys Bright Pattern Contact Center for nonprofit, CENACED, to offer remote psychological teleassistance services during the pandemic SOUTH SAN FRANCISCO, California, July 15, 2020 /PRNewswire/ -- CENACED, a non-profit healthcare organization, has deployed Bright Pattern as their clou...

2020-07-15 02:30 2130

Discover the Power of VUNO's AI Solutions at ECR 2020

SEOUL, South Korea, July 14, 2020 /PRNewswire/ -- VUNO Inc., South Korean artificial intelligence (AI) developer announced that it will attend the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020 to showcase the power of its flagship AI radiology solutions t...

2020-07-14 22:20 2011

Discover the Power of VUNO's AI Solutions at ECR 2020

University of Toronto Tests Confirm First Mask That Deactivates Coronavirus

MIRABEL, Quebec, July 14, 2020 /PRNewswire/ -- i3 BioMedical Inc. today announced that a team of scientists at theUniversity of Toronto tested and established that the virus SARS-CoV-2, which causes Covid-19, cannot be recovered after being applied to the TrioMed Active mask. The mask's external ...

2020-07-14 20:25 5135

University of Toronto Tests Confirm First Mask That Deactivates Coronavirus

UL Helps Advance Vaccination Storage Technologies with New World Health Organization Accreditation

With an anticipated surge in the need for vaccine storage in preparation for COVID-19 vaccination release, World Health Organization accredited testing will help refrigeration OEMs ensure refrigeration reliability and temperature consistency impacting overall vaccine efficacy. BENGALURU, India, ...

2020-07-14 20:00 3061

Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA

SHANGHAI, July 14, 2020 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma", stock code: 600196.SH; 02196.HK) announces that its subsidiary Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. ("Fosun Pharmaceutical Industrial") has received the acceptance no...

2020-07-14 20:00 9907

Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China

HANGZHOU, China and REHOVOT, Israel, July 14, 2020 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (stock code: 2500.HK), the leading transcatheter heart valve medical device player in China, and Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating...

2020-07-14 18:19 19030

Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia

SAN DIEGO and SAFFRON WALDEN, United Kingdom, July 14, 2020 /PRNewswire/ -- Invivoscribe, Inc., an industry pioneer and global leader in the field of precision diagnostics announces the launch of a fully integrated drug development engine. This new engine will combine with its in-house expertise ...

2020-07-14 18:00 2791

Arctic Vision Announces US$32MN in Series A to Expand and Develop Innovative Therapies Pipeline in Ophthalmology

Shanghai, July 13, 2020 /PRNewswire/ -- Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, today announced its$32mn Series A financing led by Morningside Ventures, together with its existing investors. Arctic V...

2020-07-14 09:30 3043

Revitope And Junshi Biosciences Enter Into Research Collaboration And License Agreement To Explore Next Generation Immunotherapies With Precision-Targeted T-Cell Engaging Antibodies

- Novel antibody-based cancer immunotherapies to be developed through combining Revitope's dual-antigen precision T-cell engager platform (TEAC) and Junshi Biosciences' antibodies - Revitope to design up to 5 TEAC molecules against tumor targets selected by Junshi Biosciences - For each TEAC mo...

2020-07-14 09:01 6497

Zuellig Pharma appoints John Graham as new CEO

SINGAPORE, July 14, 2020 /PRNewswire/ -- Zuellig Pharma, a leading healthcare services provider inAsia, announces the appointment of John Graham as its new CEO. John will run theUS$13 billion business and lead the team across 13 markets inAsia.

2020-07-14 09:00 9367

Zuellig Pharma appoints John Graham as new CEO

Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models

Five technologies empowering preclinical disease modeling are providing preclinical research with highly accurate and precise services SANTA CLARA, California, July 14, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Technological Advances Facilitating Research across Preclinical Disease...

2020-07-14 01:55 1502

Frost & Sullivan Reveals Technological Advances Facilitating Research across Preclinical Disease Models

NTHU Research Team Develops a Rapid Test Kit for Potential Severe Covid-19 Cases

HSINCHU, July 13, 2020 /PRNewswire/ -- Professor Cheng Chao-Min of the Institute of Biomedical Engineering at National Tsing Hua University has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more effici...

2020-07-14 01:00 1273

NTHU Research Team Develops a Rapid Test Kit for Potential Severe Covid-19 Cases

Vela Diagnostics receives CE-IVD approval and Provisional Authorisation from the Health Sciences Authority in Singapore for automated COVID-19 detection test

SINGAPORE, July 13, 2020 /PRNewswire/ -- Vela Diagnostics announced today that an automated version of its COVID-19 detection test, the ViroKey™ SARS-CoV-2 RT-PCR Test v2.0, has received the CE mark forin vitro diagnostic use as well as Provisional Authorisation from the Health Sciences Authority...

2020-07-13 17:37 1754

PQE Group Creates an Internal Research Task Force to Fight Fake News in Relation to COVID-19

FLORENCE, Italy, July 13, 2020 /PRNewswire/ -- With the pandemic caused by COVID-19, the continuous need to obtain information has pushed people to rely on unreliable sources, thus fomenting thespread of fake news. For this reason Gilda D'Incerti, CEO and founder of PQE Group

2020-07-13 16:00 2663

AVATAMED Partners CBmed in Europe on Precision Cancer Project

SINGAPORE, July 13, 2020 /PRNewswire/ -- AVATAMED and CBmed, together with AIMEDBIO and Shimadzu Corporation, are collaborating in a Precision Cancer Project, leveraging on a new technology in cancer research. The Medical Universities ofGraz and Vienna and the HEALTH Institute of Joanneum Researc...

2020-07-13 15:16 2840

AVATAMED Partners CBmed in Europe on Precision Cancer Project

SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent

TIANJIN, China, July 13, 2020 /PRNewswire/ -- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the ...

2020-07-13 15:00 5058

Kering and Hubei Red Cross Foundation Supporting Biodiversity Conservation

* Focus on wildlife protection, public health and biodiversity preservation * Join force with local organizations to enhance public awareness, community participation and science educational initiatives SHANGHAI, July 13, 2020 /PRNewswire/ -- In January, Kering made a donation ofRMB 7.5 millio...

2020-07-13 14:52 3381

Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit

SHIJIAZHUANG, China, July 13, 2020 /PRNewswire/ -- In the evening of July 12, Yiling Pharmaceutical released the performance forecast for the first half year. In the first half of this year, the company achieved a net profit attributable to shareholders of 682 million to728 million Yuan (USD 97.4...

2020-07-13 12:25 12801

1 ... 549 550 551552553 554 555 ... 608